Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Varga

Showing results (371-380 of 389) with videos related to

Pageof 39
Sort By:
Journal of Medicinal Chemistry|June 1, 1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2J J Baldwin, M E Christy, G H Denny, et al.
Scandinavian Journal of Gastroenterology|December 1, 2000
C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitorS K Balani, M E Goldman, L R Kauffman, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?P Netzer, C Gaia, S T Lourens, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonistsW J Thompson, P S Anderson, S F Britcher, et al.
Immunology Letters|June 8, 2000
Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humansS K Balani, L R Kauffman, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Sustainability Science|September 18, 2018
Engaging stakeholders in research to address water-energy-food (WEF) nexus challengesC Hoolohan, A Larkin, C McLachlan, et al.
Cell Cycle (Georgetown, Tex.)|September 17, 2009
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cellsFlorian Hohla, Stefan Buchholz, Andrew V Schally, et al.
Pageof 39

Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Journal of Medicinal Chemistry|June 1, 1986
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2J J Baldwin, M E Christy, G H Denny, et al.
Scandinavian Journal of Gastroenterology|December 1, 2000
C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1993
Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitorS K Balani, M E Goldman, L R Kauffman, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?P Netzer, C Gaia, S T Lourens, et al.
Journal of Medicinal Chemistry|February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonistsW J Thompson, P S Anderson, S F Britcher, et al.
Immunology Letters|June 8, 2000
Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2bL Bíró, L Varga, A Pár, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humansS K Balani, L R Kauffman, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Sustainability Science|September 18, 2018
Engaging stakeholders in research to address water-energy-food (WEF) nexus challengesC Hoolohan, A Larkin, C McLachlan, et al.
Cell Cycle (Georgetown, Tex.)|September 17, 2009
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cellsFlorian Hohla, Stefan Buchholz, Andrew V Schally, et al.
Pageof 39